Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Costs of tuberculosis disease in the EU – a systematic analysis and cost calculation

Roland Diel, J Vandeputte, G de Vries, J Stillo, M Wanlin, A Nienhaus
European Respiratory Journal 2013; DOI: 10.1183/09031936.00079413
Roland Diel
*Institute for Epidemiology, University Medical Hospital Schleswig-Holstein, Kiel, Germany. Member of the German Center for Lung Research (DZL)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: roland.diel@epi.uni-kiel.de
J Vandeputte
#Trivarop sprl, Colfontaine, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G de Vries
¶Regional Office The Netherlands & Europe, KNCV Tuberculosis Foundation, The Netherlands and National Institute for Public Health & the Environment, Bilthoven, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Stillo
+City University of New York Graduate Center, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Wanlin
§Belgian Lung and Tuberculosis Association, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Nienhaus
fInstitute for Health Service Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Without better vaccines it is unlikely that tuberculosis (TB) will ever be eliminated. An investment of about €560 million is considered necessary to develop a new, effective vaccine in the European Union (EU). Less is known, however, about the costs of TB disease in the EU. We performed a systematic review of literature and institutional websites addressing the 27 EU members to summarize cost data. We searched Medline, EMBASE and Cochrane bibliographies of relevant articles.

Combining direct and indirect costs, we arrived at average per-case TB costs in the old EU-15 states plus Cyprus, Malta and Slovenia of €10,282 for drug-susceptible TB, €57,213 for multidrug resistant (MDR)-TB and €170,744 for extensively drug resistant (XDR)-TB. In the remaining new EU states costs amounted to €3,427 for susceptible TB and €24,166 for MDR-TB/XDR-TB. For the 70,340 susceptible TB cases, 1,488 MDR-TB and 136 XDR-TB cases notified in 2011 total costs of €536,890,315 accumulated in 2012. For the same year, the 103,104 disability-adjusted life years (DALYs) caused by these cases, when stated in monetary terms, amounted to a total of €5,361,408,000.

Thus, the resulting economic burden of TB in the EU clearly outweighs the cost of investing in more efficient vaccines against TB.

  • Benefit
  • cost analysis
  • DALY
  • MDR-TB
  • TB elimination
  • vaccination
  • ERS
Next
Back to top
Vol 61 Issue 3 Table of Contents
European Respiratory Journal: 61 (3)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Costs of tuberculosis disease in the EU – a systematic analysis and cost calculation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Costs of tuberculosis disease in the EU – a systematic analysis and cost calculation
Roland Diel, J Vandeputte, G de Vries, J Stillo, M Wanlin, A Nienhaus
European Respiratory Journal Jan 2013, erj00794-2013; DOI: 10.1183/09031936.00079413

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Costs of tuberculosis disease in the EU – a systematic analysis and cost calculation
Roland Diel, J Vandeputte, G de Vries, J Stillo, M Wanlin, A Nienhaus
European Respiratory Journal Jan 2013, erj00794-2013; DOI: 10.1183/09031936.00079413
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Social consequences of sleep disordered breathing
  • Diagnosing airflow obstruction in COPD
Show more Original article

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society